What Happened?
Salem, NH-based AgaMatrix has Appointed Sridhar Iyengar as Chief Technology Officer
About the Company
AgaMatrix is revolutionizing health care. We`ve sold over a million devices, two billion sensors, and we are the first FDA cleared medical device/app that works with iOS. AgaMatrix is an inventor and leader in consumer healthcare technology. With fewer than 150 people, almost 50% in R&D, we develop glucose monitoring and management systems for diabetes. Diabetes related care accounts for 20% of all healthcare spending in the US. Our innovative multidisciplinary technology vision includes iPhone, Android, and web applications supported by a cloud-based, Java back end for data management and exchange between patients and their doctors. Our UI/UX won the prestigious red dot design award. Our proprietary tech platform, protected by 126 granted/pending patents, uses DSP algorithms to double accuracy while reducing cost by 50%. AgaMatrix not only developed the first FDA cleared medical device that connects to an iPhone, but has over a dozen other FDA cleared products, and has sold over 2.5M meters and 3B biosensors. Our products are available in 20,000 retail locations and a worldwide in partnership with Sanofi, the world's largest pharmaceutical company. We`ve been featured by the New York Times and Fast Company, and we work with the world`s largest retailers (Walmart, Kroger, Target) and pharmaceutical companies (Sanofi, Perrigo) to change the way diabetes is treated.
About the Person
Sridhar Iyengar drives the innovation behind the technology used by AgaMatrix that forms the foundation of WaveSense. Combining his background in electrical engineering and biological sciences, Sridhar conceived of and pioneered the concept of using Dynamic Electrochemistry™ coupled with an advanced DSP approach to enhance biosensor performance. His work in the years following his Ph.D. research is the cornerstone for AgaMatrix’s intellectual property; he has several key patents filed under his name and several others under development. Sridhar obtained his Ph.D. from the University of Cambridge as a Marshall Scholar.
Info Source
News
Short Profile